Status:
COMPLETED
Clinical Evaluation of Bacitracin
Lead Sponsor:
Mekos Laboratories AS
Conditions:
Allergic Contact Dermatitis
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to establish a concentration of a bacitracin-patch for diagnosing allergic contact dermatitis.
Detailed Description
Thin-layer Rapid Use Epicutaneous Test (T.R.U.E. Test®) is a ready-to-use patch test method designed for diagnosis of allergic contact dermatitis. The standard panel consists of two tape strips, pane...
Eligibility Criteria
Inclusion
- Positive bacitracin patch test within the latest 5 years.
- Age greater than or equal to 18 years.
- Signed informed consent.
Exclusion
- Topical treatment with corticosteroids or immunosuppressives during the latest 7 days on the test area or near the test area.
- Systemic treatment with corticosteroids or immunosuppressives during the latest 7 days.
- Treatment with ultraviolet (UV)-light during the latest 3 weeks.
- Widespread active dermatitis or dermatitis on test area.
- Breast-feeding or pregnancy. Females of childbearing potential must demonstrate a negative pregnancy test before inclusion in the study.
- Subjects not able to cooperate.
Key Trial Info
Start Date :
April 1 2005
Trial Type :
INTERVENTIONAL
End Date :
July 1 2005
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00132600
Start Date
April 1 2005
End Date
July 1 2005
Last Update
October 19 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dermatological Clinic (Joseph Fowler MD)
Louisville, Kentucky, United States, 40202